BASICS
- UI Types: stress, urge, mixed, overflow, functional.
- Stress UI: uncommon in men; often post-prostate surgery or trauma.
- Urge UI: caused by detrusor overactivity; commonly associated with bladder outlet obstruction (BPH).
- Overflow UI: bladder overdistension from poor contraction or obstruction.
- Functional UI: caused by mobility or environmental barriers.
EPIDEMIOLOGY
- 12.4% prevalence of UI in US community-dwelling adult men.
- Moderate to severe UI seen in 4.5%, with urge UI being most common.
ETIOLOGY AND PATHOPHYSIOLOGY
- Bladder abnormalities: detrusor overactivity β urge UI.
- Outlet abnormalities: sphincteric damage (surgery, radiation), neurologic disease.
- BPH compresses urethra β urinary flow obstruction.
- Mixed UI: combination bladder and outlet issues.
- Stress UI: weakened urethral sphincter or pelvic floor.
RISK FACTORS
- Age, diabetes, BPH, hypertension, depression, neurologic disease.
- History of UTIs, pelvic trauma, prostate surgery.
- Polypharmacy.
DIAGNOSIS
HISTORY
- Use 3 Incontinence Questions tool.
- Assess voiding symptoms, incontinence pattern, severity, timing.
- Review medications, surgeries, comorbidities.
- Screen for red flags: pain, hematuria, recurrent infections, fistulas.
PHYSICAL EXAM
- Abdominal: suprapubic tenderness or mass.
- Genitourinary: external genitalia, digital rectal exam (DRE) of prostate.
- Musculoskeletal & neurologic: assess for neurogenic bladder causes.
DIFFERENTIAL DIAGNOSIS
- Transient causes (infection, meds, constipation).
- Urge, stress, mixed, overflow, functional UI.
DIAGNOSTIC TESTS
- Urinalysis and culture (exclude infection).
- Postvoid residual (PVR) measurement (β₯100 mL β voiding dysfunction; >200 mL β overflow UI).
- Voiding diary, pad test (low sensitivity).
- Uroflowmetry.
- PSA as clinically indicated.
- Imaging and cystoscopy selectively.
TREATMENT
GENERAL MEASURES
- Behavioral modification: bladder training, timed voiding.
- Pelvic floor muscle training (PFMT) aids stress UI recovery post-prostatectomy.
- Weight loss recommended.
- Manage constipation, limit caffeine intake.
- Use of pads or external sheaths.
MEDICATION
- Urge UI:
- Antimuscarinic agents (oxybutynin, tolterodine, darifenacin, solifenacin, trospium, fesoterodine).
- Ξ²3-adrenergic agonist (mirabegron) as alternative or adjunct.
- Stress UI: no FDA-approved meds; topical estrogen may help postmenopausal urgency.
- Combination therapy preferred for mixed UI.
- Monitor side effects; caution in bladder outlet obstruction and high PVR.
SECOND LINE
- Tricyclic antidepressants (imipramine).
- Desmopressin for occasional short-term relief.
- Botulinum toxin intradetrusor injections (not FDA-approved).
- Duloxetine for mixed UI.
MECHANICAL DEVICES
- Pelvic floor rehab (Kegel exercises) recommended for stress and urge UI.
SURGERY
- Stress UI:
- Urethral bulking agents (modest success).
- Male sling procedures (promising short/intermediate outcomes).
- Artificial urinary sphincter (gold standard; high continence rates, revision may be needed).
- Urge UI:
- Sacral nerve stimulation.
- Augmentation cystoplasty.
- Botulinum toxin injection.
SPECIAL CONSIDERATIONS
- Geriatrics: anticholinergics and tricyclics may impair cognition.
- Monitor blood pressure with mirabegron.
ONGOING CARE
- Follow up with symptom severity indices (M-ISI, ICIQ-UI short form, Sadvik questionnaire).
- Monitor for complications.
COMPLICATIONS
- Dermatitis, candidiasis, skin breakdown.
- Social isolation, sexual dysfunction, weight gain.
REFERENCES
- Khandelwal C, Kistler C. Diagnosis of urinary incontinence. Am Fam Physician. 2013;87(8):543-550.
ICD10
- R32 Unspecified urinary incontinence
- N39.3 Stress incontinence (female) (male)
- N39.41 Urge incontinence
CLINICAL PEARLS
- Consider comorbidities as contributors to UI; treat secondary causes.
- Always check PVR; >100 mL suggests voiding dysfunction; >200 mL suggests overflow UI.
- Pelvic floor rehab beneficial in males.
- Surgical options highly effective for stress UI refractory to conservative therapy.